NDAA package revives stalled measures on US outbound investment and biotech, signalling Capitol Hill’s hardened stance ...
Precise Bio Inc., a Greensboro-based clinical-stage regenerative medicine company, has announced the world’s first transplant ...
PDS Biotechnology (PDSB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
This is a new position for Foresite Capital Management IV, LLC, representing 13.8% of reportable assets under management as ...
Spyre Therapeutics (SYRE) has strong technical momentum and is trading at a new 52 week high. ・SYRE maintains a 100% “Buy” ...
John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scient ...
We often drink less water in winter because we don't feel thirsty, but dehydration dries out the mucous membranes in the nose ...
Three biotechnology companies based in Ventura County recently received some good news from the U.S. Food and Drug Administration, gaining either approval or reviews for their treatments. These ...
Congress passes $900B defense bill targeting China with new investment restrictions, military technology bans, and 4% pay ...
Funding backs a human-first approach to drug safety and efficacy, reducing reliance on animal testing and accelerating ...
While duplicating Fido isn’t quite the ethical minefield that duplicating Uncle Fred would be, it does raise questions on ...
Explore the challenges and opportunities in enhancing India's medical research ecosystem to unlock its potential for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results